Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers
July 21 2011 - 4:05PM
Marketwired
Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today
that it has granted, subject to regulatory approval, options to
directors and officers of the company exercisable to acquire an
aggregate of 1,500,000 common shares, at a price of $0.10 per
share, expiring July 21, 2021.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS
THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
Contacts: Bradmer Pharmaceuticals Inc. Paul Van Damme
416.987.6113 pvandamme@bradmerpharma.com
Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From May 2024 to Jun 2024
Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From Jun 2023 to Jun 2024